The clinical consequences of antimicrobial resistance
The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Basis of Bacterial Outer Membrane Permeability Revisited
Nikaido, H. (2003) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.67.4.593-656.2003 · Cited by 4,316 · cited 1×
“They both use several mechanisms, including the expression of chromosomally encoded broad-spectrum b-lactamases, multidrug efflux pumps and slow or disappearing outer membrane channels (porins) to allow rapid adjustment to ongoing antimicrobial challenges [50].”
BackgroundKlevens, R. M. (2007) · JAMA · doi:10.1001/jama.298.15.1763 · Cited by 3,726 · cited 1×
“This situation has now changed with astonishing rapidity across the globe with the emergence and spread of community-associated MRSA (CA-MRSA) [11,12 ].”
BackgroundHidron, A. I., Edwards, J. R., Patel, J., Horan, T. C., Sievert, D. M., Pollock, D. A., Fridkin, S. K., & National Healthcare Safety Network Team and Participating National Healthcare Safety Network Facilities (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/591861 · Cited by 3,724 · cited 1×
“pneumoniae [24], and now in community-acquired E.”
The Changing Epidemiology of Staphylococcus aureus?
Chambers, H. F. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0702.010204 · Cited by 1,495
Growing Group of Extended-Spectrum β-Lactamases: the CTX-M Enzymes
Bonnet, R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.1-14.2004 · Cited by 1,494 · cited 2×
“In contrast to the previously much more common TEM-type and SHV-type extended-spectrum b-lactamases (ESBLs), CTX-M enzymes tend to have greater activity against ceftriaxone than ceftazidime [18].”
BackgroundResultKyaw, M. H., Lynfield, R., Schaffner, W., Craig, A. S., Hadler, J., Reingold, A., Thomas, A. R., Harrison, L. H., Bennett, N. M., Farley, M. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051642 · Cited by 881
Community-Acquired Bacterial Meningitis in Adults
van de Beek, D., de Gans, J., Tunkel, A. R., & Wijdicks, E. F. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052116 · Cited by 880
Comparative Genomics of Multidrug Resistance in Acinetobacter baumannii
Fournier, P.-E., Vallenet, D., Barbe, V., Audic, S., Ogata, H., Poirel, L., Richet, H., Robert, C., Mangenot, S., Abergel, C., et al. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020007 · Cited by 812
Staphylococcus aureus Panton-Valentine Leukocidin Causes Necrotizing Pneumonia
Labandeira-Rey, M., Couzon, F., Boisset, S., Brown, E. L., Bes, M., Benito, Y., Barbu, E. M., Vazquez, V., Höök, M., Etienne, J., et al. (2007) · Science · doi:10.1126/science.1137165 · Cited by 709
Seybold, U., Kourbatova, E. V., Johnson, J. G., Halvosa, S. J., Wang, Y. F., King, M. D., Ray, S. M., & Blumberg, H. M. (2006) · Clinical Infectious Diseases · doi:10.1086/499815 · Cited by 695
Cited by
Kumarasamy, K. K., Toleman, M. A., Walsh, T. R., Bagaria, J., Butt, F., Balakrishnan, R., Chaudhary, U., Doumith, M., Giske, C. G., Irfan, S., et al. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70143-2 · Cited by 2,922
Huh, A. J., & Kwon, Y. J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.07.002 · Cited by 1,864
Selection of Resistant Bacteria at Very Low Antibiotic Concentrations
Gullberg, E., Cao, S., Berg, O. G., Ilbäck, C., Sandegren, L., Hughes, D., & Andersson, D. I. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002158 · Cited by 1,654
Antimicrobial resistance: A global emerging threat to public health systems
Ferri, M., Ranucci, E., Romagnoli, P., & Giaccone, V. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2015.1077192 · Cited by 1,049
Combination Therapy for Treatment of Infections with Gram-Negative Bacteria
Tamma, P. D., Cosgrove, S. E., & Maragakis, L. L. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05041-11 · Cited by 836
Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria
Nikaido, H., & Pagès, J.-M. (2012) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00290.x · Cited by 769
Fishman, N., Society for Healthcare Epidemiology of America, Infectious Diseases Society of America, & Pediatric Infectious Diseases Society (2012) · Infection Control & Hospital Epidemiology · doi:10.1086/665010 · Cited by 677
Nanotechnology-Driven Therapeutic Interventions in Wound Healing: Potential Uses and Applications
Hamdan, S., Pastar, I., Drakulich, S., Dikici, E., Tomic-Canic, M., Deo, S., & Daunert, S. (2017) · ACS Central Science · doi:10.1021/acscentsci.6b00371 · Cited by 525
Antibiotic-Resistant Bacteria: A Challenge for the Food Industry
Capita, R., & Alonso-Calleja, C. (2013) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2010.519837 · Cited by 434
Multidrug Efflux Pumps in Staphylococcus aureus: an Update
Costa, S. S., Viveiros, M., Amaral, L., & Couto, I. (2013) · The Open Microbiology Journal · doi:10.2174/1874285801307010059 · Cited by 409
Desirability of Outcome Ranking (DOOR) and Response Adjusted for Duration of Antibiotic Risk (RADAR)
Evans, S. R., Rubin, D., Follmann, D., Pennello, G., Huskins, W. C., Powers, J. H., Schoenfeld, D., Chuang-Stein, C., Cosgrove, S. E., Fowler, V. G., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ495 · Cited by 361
Biomaterials and Nanotherapeutics for Enhancing Skin Wound Healing
Das, S., & Baker, A. B. (2016) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2016.00082 · Cited by 330
Catalysis and Sulfa Drug Resistance in Dihydropteroate Synthase
Yun, M.-K., Wu, Y., Li, Z., Zhao, Y., Waddell, M. B., Ferreira, A. M., Lee, R. E., Bashford, D., & White, S. W. (2012) · Science · doi:10.1126/science.1214641 · Cited by 260
Strategies for bypassing the membrane barrier in multidrug resistant Gram‐negative bacteria
Bolla, J.-M., Alibert-Franco, S., Handzlik, J., Chevalier, J., Mahamoud, A., Boyer, G., Kieć-Kononowicz, K., & Pagès, J.-M. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.04.054 · Cited by 250
“After several decades of continued success of antibiotic therapy against bacterial infections, we are now facing a worrying prospect: the accelerated evolution of antibiotic resistance of important human pathogens [1–5].”
BackgroundRamirez, M. S., Traglia, G. M., Lin, D. L., Tran, T., & Tolmasky, M. E. (2014) · Microbiology Spectrum · doi:10.1128/microbiolspec.plas-0016-2013 · Cited by 212
“belonging to the ESKAPE group (28-30), with emphasis on their role in virulence and resistance to antibiotics.”
BackgroundAndersen, J., He, G.-X., Kakarla, P., KC, R., Kumar, S., Lakra, W., Mukherjee, M., Ranaweera, I., Shrestha, U., Tran, T., et al. (2015) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph120201487 · Cited by 167
“aeruginosa [269,274].”
BackgroundNanozybiotics: advancing antimicrobial strategies through biomimetic mechanisms
Zhou, C., Wang, Q., Cao, H., Jiang, J., & Gao, L. (2024) · Advanced Materials · doi:10.1002/adma.202403362 · Cited by 114
Docquier, J.-D., Benvenuti, M., Calderone, V., Stoczko, M., Menciassi, N., Rossolini, G. M., & Mangani, S. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00409-10 · Cited by 51
Metadata
- Authors
- Rice, L. B.
- Venue
- Current Opinion in Microbiology
- Publisher
- Elsevier BV
- Published
- 2009-10
- Volume
- 12
- Issue
- 5
- Pages
- 476-481
- ISSN
- 1369-5274 (ISSN-L)
- OpenAlex
- W2052566690
- Cited by
- 291
- References
- 50
- FWCI
- 1.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.